InvestorsHub Logo
icon url

slcimmuno

03/15/15 9:05 AM

#94471 RE: KMBJN #94464

Thx for the post - much appreciated Some Sunday reading for me post qt in the mtns

Here's a link to the Espinosa Lab at U Colorado -- all things P53

http://espinosalab.org/projects
icon url

frrol

03/15/15 9:08 AM

#94472 RE: KMBJN #94464

Perhaps instead kevetrin should be combined with something that reduces p21



Perhaps not, since Kevetrin also induces PUMA, and apparently it is the PUMA/p21 ratio that matters. Great question.
icon url

To infinity and beyond!

03/15/15 9:31 AM

#94474 RE: KMBJN #94464

It is very generous for you to take the time to point out those posts, which are very interesting and helpful. I would only say that the more I read about p53 p21 PUMA etc the less clear it all seems.

It is also interesting that Phase 1 for the Aprea drug was not impressive, and yet in combo with Cisplat it may be a winner.

That suggests of course that less than sterling phase 1 for Kevetrin is not the be all or end all, just a beginning.

Thanks again.